Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Nitroglycerin Transdermal System 0.2 mg/hr (10 cm2) Recalled by Kremers Urban Pharmaceuticals, Inc. Due to Failed Impurities/Degradation Specifications: failed specification for unknown impurity...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Kremers Urban Pharmaceuticals, Inc. directly.
Affected Products
Nitroglycerin Transdermal System 0.2 mg/hr (10 cm2), For Transdermal Use Only, 30 Systems (patches) per box, Rx Only, Manufactured for: Kremers Urban Pharmaceuticals Inc., Princeton, NJ, 08540, USA, By LTS Lohmann Therapie Systeme AG, Anderach, Federal Republic of Germany, NDC 62175-123-01
Quantity: 16,832 Boxes
Why Was This Recalled?
Failed Impurities/Degradation Specifications: failed specification for unknown impurity at the 24 month stability testing.
Where Was This Sold?
This product was distributed nationwide across all 50 states.
About Kremers Urban Pharmaceuticals, Inc.
Kremers Urban Pharmaceuticals, Inc. has 3 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report